TRODELVY (sacituzumab govitecan-hziy) For Injection is used for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC)

TRODELVY is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

TRODELVY (sacituzumab govitecan-hziy) For Injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of TRODELVY (sacituzumab govitecan-hziy) For Injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the TRODELVY (sacituzumab govitecan-hziy) For Injection medicine cost price in India.

The order for TRODELVY (sacituzumab govitecan-hziy) For Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Sacituzumab govitecan, sold under the brand name Trodelvy, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate for the treatment of adults with triple-negative breast cancer (TNBC) that has spread to other parts of the body and have received at least two prior therapies.

TRODELVYTM (sacituzumab govitecan-hziy) for injection, for intravenous use. Initial U.S. Approval: 2020

Generic Name: sacituzumab govitecan-hziy

For injection: 180 mg lyophilized powder in single-dose vials for reconstitution.

TRODELVY (sacituzumab govitecan-hziy) For Injection

TRODELVY (sacituzumab govitecan-hziy) For Injection injection, for oral use is available.

Get In Touch

TRODELVY (sacituzumab govitecan-hziy) For Injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand TRODELVY (sacituzumab govitecan-hziy) Injection on prescription and Import License in Patient's Name only.

For overseas patients, TRODELVY (sacituzumab govitecan-hziy) Injection can be made available in Send your enquiry to find TRODELVY (sacituzumab govitecan-hziy) Injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for TRODELVY (sacituzumab govitecan-hziy).

For TRODELVY (sacituzumab govitecan-hziy) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Immunomedics finally wins its blockbuster FDA nod for Trodelvy in triple-negative breast cancer. For More Details

Good News For Immunomedics' Triple Negative Breast Cancer Trial For More Details

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur